An early Ethereum investor who bought 3,000 ETH at $18.83 each about nine years ago has sold all of it for approximately $7.23 million, realizing a 128x return. This sale follows a similar recent exit of 3,000 ETH from a related wallet, totaling about $15.85 million in profits since September 2025. The timing coincides with a market environment where large capital is withdrawing from ether, including outflows from ether ETFs and limits on corporate buying. Despite this, a record amount of ETH is staked, reducing available supply and potentially balancing the market impact of such large sales.
The story of an early Ethereum investor cashing out $7.23 million follows a market snapshot from Pluang as of Oct 23, 2026 19:01 WIB. For readers following major cryptocurrencies, 26 of 50 priced assets rose today while 23 fell. Notable movers include ATOM at Rp31.893 with a 3.20% gain and a Pluang order activity skewed 90% Sell / 10% Buy, FIL at Rp17.709 down 3.03% with 24% Sell / 76% Buy, and SAND at Rp949 down 2.93% with 28% Sell / 72% Buy. Typical hold times range from 61 to 124 days across these assets.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
